[ad_1]
The telecommunications and fiber company now expects $1.0 billion to $1.2 billion in free cash flow for the full year, up from a prior outlook of $100 million to $300 million.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...